Reem Mustafa, M.D., M.P.H., assistant professor of medicine and docent, has been selected to the Midwest Comparative Effectiveness Public Advisory Council (CEPAC). She is one of 14 inaugural members of the independent, non-profit research organization that will analyze and report on the effectiveness and value of new drugs and medical services.
The council is made up of clinicians, clinical research methodologists and public representatives. It is one of three public bodies convened by the Institute for Clinical and Economic Review (ICER). The Midwest group will debate ICER reports on new drugs, while considering public comment on the comparative clinical effectiveness and value of drugs that are under review.
Members of the council are experts in a broad range of disciplines such as medical ethics, outcomes research, methodology, technology assessment, patient advocacy and engagement, and clinical practice.
“The inaugural members of the Midwest CEPAC are a distinguished group of individuals, and we are proud to have them take on this critical public role,” said Steven Pearson, M.D., M.Sc., ICER president. “Patients, clinicians, insurers, and policymakers can all benefit from independent, clear judgments of what we know about which drugs work best for which patients.”
Mustafa serves as director of quality improvement and patient safety education for the internal medicine residency program, and chief of nephrology at the School of Medicine. A faculty member since 2012, her medical interests include shared decision making considering patients’ values and preferences based on the best available evidence. Her research interests include the application of principles of evidence-based medicine in clinical decision-making and guidelines development.
